Assessment of Cardiovascular Risks Due to Methylphenidate in Six Months of Treatment in Children With Attention Deficit and Hyperactivity Disorder

Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
doi 10.5455/bcp.20140702010106

Related search